New Data Affirms Strength of UCB Immuno-Dermatology Portfolio
Go back to New Data Affirms Strength of UCB Immuno-Dermatology Portfolio| (NYSE: UCB) | Delayed: 36.39 -0.16 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.55 | 52 Week High | $ | |||
| Open | $36.42 | 52 Week Low | $ | |||
| Day High | $36.55 | P/E | N/A | |||
| Day Low | $35.21 | EPS | $ | |||
| Volume | 107,325 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 127.84 +1.84 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.00 | 52 Week High | $46.25 | |||
| Open | $128.28 | 52 Week Low | $32.74 | |||
| Day High | $128.28 | P/E | N/A | |||
| Day Low | $127.23 | EPS | $0.00 | |||
| Volume | 2,994 | |||||
